# Saint Medical Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/saint-medical-co

- Industry: Medical Devices & Equipment
- Headquarters: Nanjing, China
- Website: www.saint-medical.com
- Latest round: Series A (May 1, 2022)
- Investors on record: 6

## About

Based in Nanjing, China, and established in 2019, Saint Medical Co., Ltd. is a medical equipment company that developed heart valves for cardiovascular patients. The company's founder is Dr. Chenming Ma, who majored in clinical medicine at Beijing University Charlotte Medical School, Berlin. And the company's co-founder is professor, Rüdiger Lange, who served as medical director of the Deutsches Heart Center Munich.

The company's products include spherical aortic valve replacement systems INFINCOR,  sutureless bioprosthetic valve systems ALIVE, and mitral valve replacement systems NEOCOR, and aortic valve replacement insert systems CoreValve. The company also provides a structural heart disease diagnosis platform and therapeutic technology industrialization platform.

The company will use the series A2 funding to promote the clinical trial of aortic valve replacement insert systems CoreValve and accelerate the implementation of structural heart treatment devices plus digital medicine plus medical services.

## Funding rounds

- Series A, May 1, 2022 — Kaitai Capital, Nanjing Innovation Capital Group, Nanjing Jiangbei New Area Sci-Tech Investment Group
- Series A, Jan 1, 2022 — Shenzhen HTI, Jianyuan Tianhua Investment Management (Beijing), InnoMed Capital

## Investors

- Shenzhen HTI (https://capitalatlas.ai/funds/shenzhen-hti) — Series A
- Jianyuan Tianhua Investment Management (Beijing) — Series A
- InnoMed Capital (https://capitalatlas.ai/funds/innomed-capital) — Series A
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series A
- Nanjing Innovation Capital Group — Series A
- Nanjing Jiangbei New Area Sci-Tech Investment Group — Series A
